榮譽(yù)記錄
2006年度山東大學(xué)校長(zhǎng)獎(jiǎng)學(xué)金
2006年度英國(guó)皇家學(xué)會(huì)科研獎(jiǎng)勵(lì)
山東省衛(wèi)生系統(tǒng)第三批中青年重點(diǎn)科技人才1020獎(jiǎng)勵(lì)
主講課程
藥理學(xué)，臨床藥理學(xué)，藥理學(xué)實(shí)驗(yàn)和臨床藥理學(xué)實(shí)驗(yàn)，分子藥理學(xué)，藥物篩選實(shí)驗(yàn)，藥物治療學(xué)。
科研成果
1. Yang JL, Qu XJ, Russell PJ, Goldstein D: Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon-alpha. Gut 2004,53（1）: 123-9.
2. Qu XJ, Yang JL, Russell PJ, Goldstein D: Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment. The Journal of Urology, 2004, 172: 733-738.
3. XIAN-JUN QU, YUN-XIA YUAN, ZHI-GANG TIAN, WEN-FANG XU, MING-HUI CHEN, SHU-XIANG CUI, MASATOSHI MAKUUCHI, MUNEHIRO NAKATA and WEI TANG. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2 for suppressing tumor invasion and metastasis， J Inter Molecular Med. 2006, 18（4）: 609-14.
4. XIANJUN QU, YUNXIA YUAN, WENFANG XU, MINGHUI CHEN, SHUXIANG CUI, HONG MENG, MASATOSHI MAKUUCHI, MUNEHIRO NAKATA and WEI TANG. Caffeoyl pyrrolidine derivative LY52 inhibits tumor invasion and metastasis via suppressing matrix metalloproteinase activity, Anticancer Res, 26: 5A, 3573-3578, 2006.
5. Xian-jun QU, Shu-xiang CUI, Zhigang TIAN, Xun LI, Ming-hui CHEN, Wen-fang XU, Yoshinori Inagaki, Ying-bing Deng, Masatoshi Makuuchi, Munehiro NAKATA and Wei TANG: Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10. Anticancer Res, 2007, 27: 2427-2432.
6. Jian Liu, Xun Li, Yan-na Cheng, Shu-xiang Cui, Ming-hui Chen, Wen-fang Xu, Zhi-gang Tian, Masatoshi Makuuchi, Wei Tang a,d, Xian-jun Qu：Inhibition of human gastric carcinoma cell growth by treatment of N3-o-toluyl-fluorouracil as a precursor of 5-fluorouracil Eur J Pharmacol. 2007; 574（1）:1-7.
7. Subo Wang, Yanna Cheng, Fengshan Wang, Lirui Sun, Chunhui Liu,
Guanjun Chen, Yuhua Li, S.G. Ward, Xianjun Qu：Inhibition activity of sulfated polysaccharide of Sepiella maindroni ink on matrix metalloproteinase （MMP）-2 Biomedicine & Pharmacotherapy （2008） 62（5）: 297-302.
8. Li-rui Sun, Xun Li, Yan-na Cheng, Hong-yu Yuan, Ming-hui Chen, Wei Tang, Stephen Geoffrey Ward, Xian-jun Qu. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells Biomedicine & Pharmacotherapy xx （2008） 1-7.
9. Chen MH, Cui SX, Cheng YN, Sun LR, Li QB, Xu WF, Ward SG, Tang W, Qu XJ. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Anticancer Drugs. 2008;19（10）:957-965.
10. Meng Ma, Xian-Jun Qu, Guo-Ying Mu, Ming-Hui Chen, Yan-Na Cheng, Norihiro Kokudo, Wei Tang, Shu- Xiang Cui. Vitamin K2 Inhibits the Growth of Hepatocellular Carcinoma via Decrease of Des-gamma-carboxy Prothrombin. Chemotherapy, 2009; 55:28-35.（DOI:10.1159/000167022）.
11. Fu-Jun Gao, Shu-Xiang Cui, Ming-Hui Chen, Yan-Na Cheng, Li-Rui Sun, S. G Ward, Norihiro Kokudo, Wei Tang, Xian-Jun Qu: Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sciences 2008, 83; 815-820.
承擔(dān)項(xiàng)目
1. 國(guó)家自然基金項(xiàng)目“以Pgp為靶點(diǎn)的喹喔啉酮化合物對(duì)腫瘤細(xì)胞耐藥性的逆轉(zhuǎn)作用研究”，首位承擔(dān)人。時(shí)間: 2007-2009年。
2. 國(guó)家自然基金項(xiàng)目“吡咯烷類MMP抑制劑抗癌作用機(jī)制及構(gòu)效關(guān)系研究”，首位承擔(dān)人，30472038。時(shí)間: 2005-2007年。
3. 以MMP-2,9為靶點(diǎn)的吡咯烷類化合物抗腫瘤轉(zhuǎn)移作用研究，山東省衛(wèi)生系統(tǒng)第三中青年重點(diǎn)科技人才資助計(jì)劃1020。
